Bank of America
EIKN

Bank of America’s Eikon Therapeutics EIKN Stock Holding History

Bank of America’s Portfolio EIKN Stock Details EIKN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$911K Buy
+86,134
New +$1.15M ﹤0.01% 4564

Other funds holding EIKN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCMI
Foresite Capital Management IV Larkspur, California $237M AUM 107.53% 1-Year Est. Return
MC
Merck & Co Kenilworth, New Jersey $526M AUM 175.27% 1-Year Est. Return
FCMV
Foresite Capital Management V Larkspur, California $271M AUM 309.87% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Bank of America's EIKN Position: Q1 2026 in Review

Bank of America opened a new position in Eikon Therapeutics (EIKN) in Q1 2026: 86,134 shares worth $911K. The stake represents ﹤0.01% of the portfolio and ranks #4564 among its holdings.

52 funds tracked by Wall St. Rank hold EIKN as of Q1 2026.

  • Bank of America held 86,134 shares of Eikon Therapeutics worth $911K as of Q1 2026.
  • Eikon Therapeutics was a new Bank of America position in Q1 2026.
  • Eikon Therapeutics made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #4564 holding.
  • 52 funds tracked by Wall St. Rank held Eikon Therapeutics as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.